Financial Post
🏢 Postmedia
Aug 4, 2026
· 1 min read
AI Analyzed
○ Unverifiable
View full audit trail →
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · CENTER
ML v2 (DistilBERT)
0.308 · RIGHT
Ensemble
0.154 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.021
4,354 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
Article Excerpt
Accomplished life sciences leader with a proven track record of driving successful development of novel therapeutics, joins Mosaic to guide its next phase of growth Allison brings three decades of drug development, board and executive leadership experience to support Mosaic’s transition towards a clinical-stage company CAMBRIDGE, England — Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) […]
Read full article at Financial Post ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
pending
Aug 4, 2026